Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

INSPIRE MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP

INSP

NEW ORLEANS, LA / ACCESSWIRE / January 25, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilFebruary 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE:INSP), if they purchased the Company's shares between May 3, 2023 and November 7, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Minnesota.

What You May Do

If you purchased shares of Inspire and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-insp/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 20, 2024.

About the Lawsuit

Inspire Medical and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On November 7, 2023, post-market, the Company disclosed disappointing financial results for 3Q 2023, including "a decline in prior authorization submissions for patients seeking Inspire therapy," as well as problems with its highly touted "Acceleration Program" requiring "some corrective action."

On this news, shares of Inspire Medical plummeted approximately 20%, from a closing price of $161.74 per share on November 7, 2023, to a closing price of $129.95 per share on November 8, 2023.

The case is City of Hollywood Firefighters' Pension Fund v. Inspire Medical Systems, Inc., No. 23-cv-03884.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients - including public institutional investors, hedge funds, money managers and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.

To learn more about KSF, you may visit http://ksfcounsel.com/.

CONTACT:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

SOURCE: Kahn Swick & Foti, LLC



View the original press release on accesswire.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today